RT - Article
SR - Electronic
T1 - 
SP - 2021-04-23
DO - 10.1007/s11094-021-02364-6
A1 - , 
A1 - , 
A1 - , 
A1 - , 
A1 - , 
A1 - , 
YR - 2021
UL - https://repo.bashgmu.ru/publication/2356
AB - The pharmacokinetic parameters of the parent substance and the injectable dosage form of the new antiplatelet drug 3-methyl-8-(piperazin-1-yl)-7-(thietan-3-yl)-1-ethyl-1H-purine-2,6(3H,7H)-dione hydrochloride in rabbit blood plasma upon intravenous administration were compared and analyzed. The relative bioavailability coefficient was determined to be 0.97.